Regorafenib
id:
regorafenib-167-16828035
title:
Regorafenib
text:
Regorafenib, sold under the brand name Stivarga among others, is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types. By 2015 it had two US approvals for advanced cancers.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Regorafenib
date created:
2009-09-19T06:58:26Z
date modified:
2024-08-30T20:27:32Z
main entity:
{"identifier":"Q3891664","url":"https://www.wikidata.org/entity/Q3891664"}
image:
fields total:
13
integrity:
15